Clinical Trial Update: A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ALN-BCAT in patients with hepatocellular carcinoma (advanced or metastatic) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ALN-BCAT

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING